{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:10:56Z","timestamp":1776251456294,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LY18H160020"],"award-info":[{"award-number":["LY18H160020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04743-5","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T17:32:12Z","timestamp":1772991132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DENND2D serves as a novel prognostic biomarker with paradoxical protumorigenic effects in glioma"],"prefix":"10.1007","volume":"17","author":[{"given":"Hongxing","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linghao","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiang","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zebin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijian","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renya","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhouying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,8]]},"reference":[{"key":"4743_CR1","doi-asserted-by":"publisher","first-page":"n1560","DOI":"10.1136\/bmj.n1560","volume":"374","author":"C McKinnon","year":"2021","unstructured":"McKinnon C, Nandhabalan M, Murray SA, Plaha P. Glioblastoma: clinical presentation, diagnosis, and management. BMJ. 2021;374:n1560.","journal-title":"BMJ"},{"issue":"17","key":"4743_CR2","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/jama.2013.280319","volume":"310","author":"A Omuro","year":"2013","unstructured":"Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310(17):1842\u201350.","journal-title":"JAMA"},{"issue":"21","key":"4743_CR3","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1200\/JCO.2017.73.0119","volume":"35","author":"BM Alexander","year":"2017","unstructured":"Alexander BM, Cloughesy TF. Adult Glioblastoma. J Clin Oncol. 2017;35(21):2402\u20139.","journal-title":"J Clin Oncol"},{"issue":"19","key":"4743_CR4","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1158\/1078-0432.CCR-23-0388","volume":"29","author":"Q Xu","year":"2023","unstructured":"Xu Q, Huang K, Meng X, Weng Y, Zhang L, Bu L, Zheng X, Cai J, Zhan R, Chen Q. Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma. Clin Cancer Res. 2023;29(19):3859\u201366.","journal-title":"Clin Cancer Res"},{"issue":"37","key":"4743_CR5","doi-asserted-by":"publisher","first-page":"33008","DOI":"10.1021\/acsnano.5c11629","volume":"19","author":"S Muhammad","year":"2025","unstructured":"Muhammad S, Maridevaru MC, Roy S, Chen D, Zeng W, Sun L, Zhang Y, Guo B. Piezodynamic Therapy: Unleashing Mechanical Energy and Featuristic Next Generation Therapeutic Paradigms for Glioblastoma. ACS Nano. 2025;19(37):33008\u201358.","journal-title":"ACS Nano"},{"issue":"8","key":"4743_CR6","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.7150\/ijbs.71046","volume":"18","author":"L Zhang","year":"2022","unstructured":"Zhang L, Wang Y, Peng Z, Weng Y, Fang Z, Xiao F, Zhang C, Fan Z, Huang K, Zhu Y, Jiang W, Shen J, Zhan R. The progress of multimodal imaging combination and subregion based radiomics research of cancers. Int J Biol Sci. 2022;18(8):3458\u201369.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"4743_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"D1","key":"4743_CR8","doi-asserted-by":"publisher","first-page":"D888","DOI":"10.1093\/nar\/gkw1123","volume":"45","author":"Y Xiong","year":"2017","unstructured":"Xiong Y, Wei Y, Gu Y, Zhang S, Lyu J, Zhang B, Chen C, Zhu J, Wang Y, Liu H, Zhang Y. DiseaseMeth version 2.0: a major expansion and update of the human disease methylation database. Nucleic Acids Res. 2017;45(D1):D888\u201395.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4743_CR9","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/s41467-024-45693-2","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Gao B, Zhang L, Wang X, Zhu X, Yang H, Zhang F, Zhu X, Zhou B, Yao S, Nagayama A, Lee S, Ouyang J, Koh SB, Eisenhauer EL, Zarrella D, Lu K, Rueda BR, Zou L, Su XA, Yeku O, Ellisen LW, Wang XS, Lan L. Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair. Nat Commun. 2024;15(1):1568.","journal-title":"Nat Commun"},{"issue":"1","key":"4743_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3892\/ijo.2013.2165","volume":"44","author":"M Kanda","year":"2014","unstructured":"Kanda M, Nomoto S, Oya H, Takami H, Hibino S, Hishida M, et al. Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma. Int J Oncol. 2014;44(1):44\u201352.","journal-title":"Int J Oncol"},{"issue":"1","key":"4743_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/biomedicines13010025","volume":"13","author":"CF Chang","year":"2024","unstructured":"Chang CF, Chen LC, Chen YT, Huang CY, Yu CC, Lin VC, et al. Unveiling DENND2D as a Novel Prognostic Biomarker for Prostate Cancer Recurrence: From Gene to Prognosis. Biomedicines. 2024;13(1):25.","journal-title":"Biomedicines"},{"issue":"2","key":"4743_CR12","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3892\/or.2013.2901","volume":"31","author":"S Hibino","year":"2014","unstructured":"Hibino S, Kanda M, Oya H, Takami H, Shimizu D, Nomoto S, et al. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus. Oncol Rep. 2014;31(2):693\u2013700.","journal-title":"Oncol Rep"},{"issue":"2","key":"4743_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.lungcan.2012.10.012","volume":"79","author":"B Ling","year":"2013","unstructured":"Ling B, Zheng H, Fu G, Yuan J, Shi T, Chen S, et al. Suppression of non-small cell lung cancer proliferation and tumorigenicity by DENND2D. Lung Cancer. 2013;79(2):104\u201310.","journal-title":"Lung Cancer"},{"key":"4743_CR14","doi-asserted-by":"publisher","first-page":"38750","DOI":"10.1038\/srep38750","volume":"6","author":"S Sakha","year":"2016","unstructured":"Sakha S, Muramatsu T, Ueda K, Inazawa J. Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma. Sci Rep. 2016;6:38750.","journal-title":"Sci Rep"},{"issue":"5","key":"4743_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41419-022-04885-8","volume":"13","author":"WJ Ma","year":"2022","unstructured":"Ma WJ, Chen Y, Peng JH, Tang C, Zhang L, Liu M, Hu S, Xu H, Tan H, Gu Y, Pan ZZ, Chen G, Zhou ZG, Zhang RX. Stage IV colon cancer patients without DENND2D expression benefit more from neoadjuvant chemotherapy. Cell Death Dis. 2022;13(5):439.","journal-title":"Cell Death Dis"},{"issue":"19","key":"4743_CR16","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1158\/1078-0432.CCR-23-0388","volume":"29","author":"Q Xu","year":"2023","unstructured":"Xu Q, Huang K, Meng X, Weng Y, Zhang L, Bu L, et al. Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma. Clin Cancer Res. 2023;29(19):3859\u201366.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"4743_CR17","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.immuni.2025.04.017","volume":"58","author":"KW Song","year":"2025","unstructured":"Song KW, Lim M, Monje M. Complex neural-immune interactions shape glioma immunotherapy. Immunity. 2025;58(5):1140\u201360.","journal-title":"Immunity"},{"issue":"9","key":"4743_CR18","first-page":"4312","volume":"12","author":"F Xiao","year":"2022","unstructured":"Xiao F, Shen J, Zhou L, Fang Z, Weng Y, Zhang C, et al. ZNF395 facilitates macrophage polarization and impacts the prognosis of glioma. Am J Cancer Res. 2022;12(9):4312\u201325.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"4743_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","volume":"6","author":"X Xiang","year":"2021","unstructured":"Xiang X, Wang J, Lu D, Xu X. Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduct Target Ther. 2021;6(1):75.","journal-title":"Signal Transduct Target Ther"},{"issue":"14","key":"4743_CR20","doi-asserted-by":"publisher","first-page":"e2321611121","DOI":"10.1073\/pnas.2321611121","volume":"121","author":"R Wu","year":"2024","unstructured":"Wu R, Sun C, Chen X, Yang R, Luan Y, Zhao X, Yu P, Luo R, Hou Y, Tian R, Bian S, Li Y, Dong Y, Liu Q, Dai W, Fan Z, Yan R, Pan B, Feng S, Wu J, Chen F, Yang C, Wang H, Dai H, Shu M. NSUN5\/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion. Proc Natl Acad Sci U S A. 2024;121(14):e2321611121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4743_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12943-017-0598-7","volume":"16","author":"Y Wang","year":"2017","unstructured":"Wang Y, Mo Y, Gong Z, Yang X, Yang M, Zhang S, et al. Circular RNAs in human cancer. Mol Cancer. 2017;16(1):25.","journal-title":"Mol Cancer"},{"issue":"3","key":"4743_CR22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s11427-023-2737-2","volume":"68","author":"D Wang","year":"2025","unstructured":"Wang D, Zuo S, Ge J, Qu H, Wu J, Yi N, et al. circTP63-N suppresses the proliferation and metastasis of nasopharyngeal carcinoma via engaging with HSP90AB1 to modulate the YAP1\/Hippo signaling pathway. Sci China Life Sci. 2025;68(3):689\u2013705.","journal-title":"Sci China Life Sci"},{"key":"4743_CR23","doi-asserted-by":"publisher","first-page":"216614","DOI":"10.1016\/j.canlet.2024.216614","volume":"584","author":"X Yan","year":"2024","unstructured":"Yan X, Zhang M, Wang D. Interplay between posttranslational modifications and liquid\u2013liquid phase separation in tumors. Cancer Lett. 2024;584:216614.","journal-title":"Cancer Lett"},{"issue":"1","key":"4743_CR24","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41420-025-02599-2","volume":"11","author":"H Chen","year":"2025","unstructured":"Chen H, Huang S, Quan L, Yu C, Zhu Y, Sun X, et al. Liquid\u2013liquid phase separation: a potentially fundamental mechanism of sepsis. Cell Death Discov. 2025;11(1):310.","journal-title":"Cell Death Discov"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04743-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04743-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04743-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:29:30Z","timestamp":1776248970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04743-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,8]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4743"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04743-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,8]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Medical Ethics Committee of The First Affiliated Hospital, Zhejiang University School of Medicine (#2019-52). The patient provided written informed consent for publication of this case report and the associated images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"572"}}